Found 1829 clinical trials
A Phase I Study of AL8326 in Advanced Solid Tumor
Main purpose Objective to study the tolerance and safety of single and multiple administration of repeated 28-day cycles of AL8326 in patients with advanced solid tumor, observe the dose
- 0 views
- 24 May, 2021
- 2 locations
Safety Study of AB0024 in Patients With Advanced Solid Tumors
This is a first-in-human, open-label, sequential dose escalation study to evaluate AB0024 in patients with advanced solid tumors.
- 20 views
- 08 Nov, 2020
- 2 locations
A Study of SKB315 in Patients With Advanced Solid Tumors
injection in patients with advanced solid tumors.
- 0 views
- 26 May, 2022
- 1 location
Study of RP-6306 With Gemcitabine in Advanced Solid Tumors
The primary purpose of this study is to assess the safety and tolerability of RP-6306 in combination gemcitabine, in patients with eligible advanced solid tumors, determine the maximum tolerated
- 0 views
- 28 May, 2022
- 4 locations
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
This study is a Phase 1, first-in-human, open-label, dose-escalation and cohort expansion study designed to characterize the safety, tolerability, pharmacokinetics, preliminary antitumor activity and immunogenicity of 9MW2821 administered by intravenous (IV) infusion.
- 0 views
- 10 Apr, 2023
- 2 locations
A Study of DB-1311 in Advanced/Metastatic Solid Tumors
This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1311 in subjects with advanced solid tumors.
- 0 views
- 16 Sep, 2023
Study on TIL for the Treatment of Advanced Solid Tumors
This study is to investigate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy in patients with Advanced malignant solid tumors.Autologous TILs are expanded from tumor resections or biopsies and infused i.v. into the patient after NMA lymphodepletion treatment with hydroxychloroquine(600mg,single-dose) and cyclophosphamide.
- 11 views
- 02 Oct, 2023
- 1 location
KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor
advanced HER2 positive solid tumors.
- 0 views
- 24 Apr, 2022
- 1 location
A Study of EMB-02 in Participants With Advanced Solid Tumors
The primary purpose of this study is to identify the recommended Phase 2 dose(s) (RP2Ds) and schedule assessed to be safe for EMB-02 and to characterize the safety and tolerability of EMB-02 at the RP2Ds. Pharmacokinetics (PK), immunogenicity, and the anti-tumor activity of EMB-02 will also be assessed.
- 0 views
- 24 Apr, 2022
- 6 locations
A Study of ASP1002 in Adults for Treatment of Solid Tumors
ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how it is processed by and acts upon the
- 0 views
- 28 Aug, 2023
- 6 locations